1:03 / 7:30 • Key Successes Futura Medical marks pivotal year with first meaningful revenue from Eroxon sales - James Barder, CEO, Futura Medical 00:00:00
Futura Medical PLC CEO James Barder tells Proactive's Stephen Gunnion that 2023 was a pivotal year for the company as it rolled out its innovative sexual health product, Eroxon, designed to treat erectile dysfunction. The over-the-counter availability of Eroxon distinguishes it as a groundbreaking product globally, facilitating easier access for consumers without a prescription.
